Page 129 - 《中国药房》2021年第1期

pheral blood lymphocytes against nicotine-induced cellu- [21] RINGDÉN O，REMBERGER M，LEHMANN S，et al. N-
lar and DNA damage in vitro：with the comparison of acetylcysteine for hepatic veno-occlusive disease after al-
N-acetylcysteine[J]. Toxicology，2007，230（1）：11-21. logeneic stem cell transplantation[J]. Bone Marrow Trans-
[10] 张静，吴瑜，徐敬根，等. N-乙酰-L-半胱氨酸对H2O2引起 plant，2000，25（9）：993-996.
的血管内皮细胞损伤的拮抗效应[J].中国呼吸与危重监 [22] SJÖÖ F，ASCHAN J，BARKHOLT L，et al.N-acetyl-L-
护杂志，2003，2（2）：91-94. cysteine does not affect the pharmacokinetics or myelo-
[11] DE FLORA S，IZZOTTI A，D’AGOSTINI F，et al. Mech- suppressive effect of busulfan during conditioning prior to
anisms of N-acetylcysteine in the prevention of DNA da- allogeneic stem cell transplantation[J]. Bone Marrow
mage and cancer，with special reference to smoking-relat- Transplant，2003，32（4）：349-354.
ed end-points[J]. Carcinogenesis，2001，22（7）：999-1013. [23] LEE AC，GOH PY. Dactinomycin-induced hepatic sinusoi-
[12] 王振花，李潮生，李晓丽，等.乙酰半胱氨酸在各系统疾病 dal obstruction syndrome responding to treatment with
防治中的研究进展[J].医学综述，2019，25（11）：2138- N-acetylcysteine[J]. J Cancer，2011，2（1）：527-531.
2142. [24] SAHOO RK，SHARMA A. Sinusoidal obstruction syn-
[13] CHIEW AL，REITH D，POMERLEAU A，et al. Updated drome during induction therapy for acute lymphoblastic
guidelines for the management of paracetamol poisoning leukemia managed with N-acetylcysteine[J]. Pediatric
in Australia and New Zealand[J]. Med J Aust，2020，212 Blood Cancer，2011. DOI：10.1002/pbc.23142.
（4）：175-183. [25] BARKHOLT L，REMBERGER M，HASSAN Z，et al. A
[14] Food and Drug Administration. Highlights of prescribing prospective randomized study using N-acetyl-L-cysteine
information（ACETADOTE）[EB/OL].（2020-01-13） for early liver toxicity after allogeneic hematopoietic stem
[2020-08-13].http：//www.accessdata.fda.gov/drugsatf- cell transplantation[J]. Bone Marrow Transplant，2008，41
da_docs/label/2019/021539s017lbl.pdf. （9）：785-790.
[15] 张玮，诸葛宇征.《吡咯生物碱相关肝窦阻塞综合征诊断 [26] EL-SERAFI I，REMBERGER M，EL-SERAFI A，et al.
和治疗专家共识意见（2017 年，南京）》解读[J].医学新 The effect of N-acetyl-L-cysteine（NAC）on liver toxicity
知，2019，29（1）：17-20. and clinical outcome after hematopoietic stem cell trans-
[16] DIGNAN FL，WYNN RF，HADZIC N，et al. BCSH/ plantation[J]. Sci Rep，2018，8（1）：1-10.
BSBMT guideline：diagnosis and management of veno- [27] SCULLY M，HUNT BJ，BENJAMIN S，et al. Guidelines
occlusive disease（sinusoidal obstruction syndrome）fol- on the diagnosis and management of thrombotic thrombo-
lowing haematopoietic stem cell transplantation[J]. Br J cytopenic purpura and other thrombotic microangiopa-
Haematol，2013，163（4）：444-457. thies[J]. Br J Haematol，2012，158（3）：323-335.
[17] MOHTY M，MALARD F，ABECASSIS M，et al.Sinusoi- [28] BLOMBERY P，SCULLY M. Management of thrombotic
dal obstruction syndrome/veno-occlusive disease：current thrombocytopenic purpura： current perspectives[J]. J
situation and perspectives：a position statement from the Blood Med，2014，5：15-23.
European Society for Blood and Marrow Transplantation [29] COPPO P. Management of thrombotic thrombocytopenic
（EBMT）[J]. Bone Marrow Transplant，2015，50（6）：781- purpura[J]. Transfus Clin Et Biol，2017，109（3）：496-507.
789. [30] GEORGE JN，LÓPEZ JA，KONKLE BA. N-acetylcyste-
[18] SHULMAN HM，HINTERBERGER W. Hepatic veno-oc- ine：an old drug，a new insight，a potentially effective treat-
clusive disease：liver toxicity syndrome after bone marrow ment for thrombotic thrombocytopenic purpura[J]. Trans-
transplantation[J]. Bone Marrow Transplant，1992，10（3）： fusion，2014，54（5）：1205-1207.
197-214. [31] CHEN J，REHEMAN A，GUSHIKEN FC，et al. N-acetyl-
[19] ALLEN JR，CARSTENS LA，KATAGIRI GJ. Hepatic cysteine reduces the size and activity of von Willebrand
veins of monkeys with veno-occlusive disease. Sequential factor in human plasma and mice[J]. J Clin Invest，2011，
ultrastructural changes[J]. Arch Pathol，1969，87（3）：279- 121（2）：593-603.
289. [32] TERSTEEG C，ROODT J，VAN RENSBURG WJ，et al.
[20] BAUMGARDNER JN，KARTIK S，LEAH H，et al. N-ace- N-acetylcysteine in preclinical mouse and baboon models
tylcysteine attenuates progression of liver pathology in a of thrombotic thrombocytopenic purpura[J]. Blood，2016，
rat model of nonalcoholic steatohepatitis[J]. J Nutr，2008， 129（8）：1030-1038.
138（10）：1872-1879. [33] SAYANI FA，ABRAMS CS. How I treat refractory throm-

中国药房 2021年第32卷第1期 China Pharmacy 2021 Vol. 32 No. 1 ·119 ·